GLG News by Restasis (Cyclosporine) Ophthalmic Emulsion Prescribers: Ophthalmologists (US)

The Phase III Trials of Xibrom showed excellent efficacy in the treatment of post cataract surgery pain and inflammation.  The trial involved 500 cataract patients and is important in that it demonstrates that a once-a-day formulation is effacacious in treating patients post-operatively. ...

The Center for Medicare and Medicaid Services (CMS) has ruled that beneficiaries may pay out of pocket for additional non-covered services related to presbyopia and astigmatism correcting intraocular lenses (IOLs) that are provided by surgeons and facilities (such as Ambulatory Surgery Centers and Hospital...

This lay article proves again that lawyers are actively pursuing litigation in this profitable field.  Given that over 1 million people per year have this surgery, and physicians are under constant pressure to increase patient volumes, it is a potentially dangerous combination. ...

There has been a sea change in the treatment of postoperative cataract patients. The addition of a nonsteroidal has significantly reduced postoperative complications such as edema, discomfort and inflammation.Compliance with all medications is always an issue, and the use of a once daily medication...

This article describes the Phase II trial results of the PreView Scleral Implants (ReFocus Group Inc.) for the treatment of presbyopia.  Presbyopia is the natural age related loss of accommodation, or near focusing ability that leads to people wearing reading glasses. Scleral implants alter the...

AMO's acquisition of Intralase for $808 million has been seen by most financial industry analysts as positive.  Most financial analysts point to the improved diversification and strengthening of AMO's refractive portfolio which includes intraocular lenses, phacoemulsification equipment, VISX excimer...

It is reported today that AMO will purchase Intralase Corp for 808 million dollars in what could securely position AMO as the world leader in all aspects of LASIK and laser vision correction technology. For months it has been speculated that such a purchase would occur.

While the use of Intacs has practically ended for routine correction of myopia, and the company management and ownership has shifted several times in the last few years, there has been a great interest and success in using these implants for the stabilization of eyes with ectasias such as keratoconus...

This article describes the results of a "newer" refractive surgery technique known as sub-Bowman's keratomileusis or SBK.  SBK involves creating a corneal flap just below the epithelial layer of the cornea.  This flap is approximately 60-70 microns in thickness compared to a traditional...

Despite short term patient satisfaction for the correction of myopia, with the multiple problems and issues associated with the approval of the Visian ICL (phakic iol) for correction of myopia over the past several years, and some studies that indicated higher corneal endothelial cell count loss and...